5 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... Note: Systemic antifungals ... mucosal #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
adjusting the dose ... differential #algorithm #management ... #table #foamed ... #heartfailure #chf ... icu #clinical #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... #valleyfever #management ... #treatment #antifungals ... #comparison #table ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
Therapy: • Perform CSF ... consultation to guide management ... pallidum #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
months or • RFB (dose ... Please refer to the table ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology